A highly significant increase in mRNA and protein levels of TGFβ receptor II (TβRII) was detected in SSc BM-MSCs as compared to healthy controls.
← all excerpts
Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use?
1
—
—